Determination of optimal virtual monochromatic energy level for target delineation of brain metastases in radiosurgery using dual-energy CT.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
01 Feb 2020
Historique:
pubmed: 12 12 2019
medline: 6 2 2020
entrez: 12 12 2019
Statut: ppublish

Résumé

Determination of the optimal energy level of virtual monochromatic image (VMI) for brain metastases in contrast-enhanced dual-energy CT (DECT) for radiosurgery and assessment of the subjective and objective image quality of VMI at the optimal energy level. 20 patients (total of 42 metastases) underwent contrast-enhanced DECT. Spectral image analysis of VMIs at energy levels ranging from 40 to 140 keV in 1 keV increments was performed to determine the optimal VMI (VMI The VMI at 63 keV was defined as VMI The VMI at 63 keV derived from contrast-enhanced DECT yielded the highest CNR and improved the objective and subjective image quality for radiosurgery, compared to VMI This paper investigated for the first time the optimal energy level of VMI in DECT for brain metastases. The findings will lead to improvement in tumor visibility with optimal VMI and consequently supplement accuracy delineation of brain metastases.

Identifiants

pubmed: 31825643
doi: 10.1259/bjr.20180850
pmc: PMC7055442
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20180850

Références

AJNR Am J Neuroradiol. 2015 Aug;36(8):1518-24
pubmed: 26021623
Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):821-7
pubmed: 11395252
Med Phys. 2017 Jul;44(7):e43-e76
pubmed: 28376237
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):714-22
pubmed: 19095373
Radiology. 2013 Jan;266(1):318-25
pubmed: 23074259
Radiother Oncol. 2018 Oct;129(1):105-111
pubmed: 29422428
AJNR Am J Neuroradiol. 2012 May;33(5):803-17
pubmed: 22016411
Eur Radiol. 2018 Nov;28(11):4514-4523
pubmed: 29761357
Pediatr Radiol. 2017 Nov;47(12):1648-1658
pubmed: 28656326
Abdom Imaging. 2015 Jun;40(5):1230-40
pubmed: 25331567
Invest Radiol. 2012 May;47(5):292-8
pubmed: 22472797
Jpn J Radiol. 2018 Feb;36(2):69-80
pubmed: 29119457
Clin Oncol (R Coll Radiol). 2011 Nov;23(9):646-51
pubmed: 21592754
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):830-840
pubmed: 30003998
AJR Am J Roentgenol. 2012 Nov;199(5 Suppl):S98-S105
pubmed: 23097174
Phys Med. 2019 Apr;60:83-90
pubmed: 31000091
J Neurooncol. 2005 Oct;75(1):5-14
pubmed: 16215811
Neuroimaging Clin N Am. 2017 Aug;27(3):385-400
pubmed: 28711200
J Neurol. 2002 Oct;249(10):1357-69
pubmed: 12382150
Br J Radiol. 2004 Jan;77(913):39-42
pubmed: 14988136
Invest Radiol. 2017 Aug;52(8):470-476
pubmed: 28422806
Insights Imaging. 2011 Apr;2(2):149-159
pubmed: 22347944
Radiother Oncol. 2001 Jul;60(1):49-59
pubmed: 11410304

Auteurs

Tsukasa Karino (T)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Shingo Ohira (S)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
Department of Medical Physics and Engineering, Osaka University Graduate of Medicine, Osaka, Japan.

Naoyuki Kanayama (N)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Kentaro Wada (K)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Toshiki Ikawa (T)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Yuya Nitta (Y)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Hayate Washio (H)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Masayoshi Miyazaki (M)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
Department of Radiology, Hyogo College of Medicine, Hyogo, Japan.

Teruki Teshima (T)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH